Sartorius debuts the Intellicyt iQue3 at CYTO® 2019
Sartorius debuts their new product, the Intellicyt iQue3, at this year's CYTO® conference and exhibition.
List view / Grid view
Sartorius debuts their new product, the Intellicyt iQue3, at this year's CYTO® conference and exhibition.
Mosaic Sample Management is Titian Software’s comprehensive, customisable, modular software product to control and monitor all aspects of sample storage, preparation and delivery.
Unique considerations surrounding the bureaucracy and oversight in the use of human biospecimens in the European Union.
Nuclear magnetic resonance measurement and state-of-the-art computational science reveal protein structures in higher eukaryotic cells.
New method for computational mass spectrometry will speed up the discovery of natural products that could be used in medicines...
Data drives drug discovery, yet it continues to be among the biggest challenges faced by the industry.1 Experiments are often not repeatable and data interpretation is subject to the biases and limitations of human beings.
In this In-Depth Focus: AI-driven automated chemistry as a tool to accelerate drug discovery, and a look at network-driven drug discovery
In this issue: AI-driven automated chemistry as a tool to accelerate drug discovery processes, the shifting landscape of immuno-oncology, and how lipid molecules provide an insight into biological research.
Target-driven drug discovery, in which the starting point is a specific protein target hypothesised to play an important role in disease, has been the dominant paradigm for the last few decades. However, phenotypic-driven drug discovery, which does not rely on a specific target hypothesis, is starting to regain traction for…
Learn everything you need to know about the most widely-used mouse in biomedical research with this free whitepaper.
Learn how the continued development of CRISPR gene editing technologies opens fresh possibilities for in vivo model design.
Proteomics research has become a popular method for characterising functional proteins as well as discovering the innovative targets for oncologic disorders...
Every day scientists are working to discover and develop new therapies and treatments to change the lives of patients suffering from serious and debilitating illnesses. Amgen Inc. has made it a priority to unlock the potential of biology to discover, develop, manufacture, and deliver innovative therapeutics to patients.
Many bioanalytical labs work with a crowded and siloed set of systems and processes. From part electronic to part paper-based workflows to standalone point-solutions, the result is a lack of insight into data and slower reporting and results handling.